Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -342.41 Thousand | -554.68 Thousand | -170.77 Thousand | -2.51 Million | -6.37 Million |
| Net Income | -3.01 Million | -64.88 Million | -85.03 Million | 190.06 Million | -6.18 Million |
| Depreciation & Amortization | 2972.00 | 13.48 Thousand | 38.56 Thousand | 39.3 Thousand | 42.77 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 471.53 Thousand | 153 Thousand | 270.5 Thousand | 446.6 Thousand | 1.43 Million |
| Change in working capital | 249.21 Thousand | -225.22 Thousand | 82.05 Thousand | -52.22 Thousand | 398.91 Thousand |
| Other non-cash items | 2.16 Million | 64.39 Million | 84.5 Million | -13.54 Million | -349.02 Thousand |
| Investing Cash Flow | - | -13.99 Thousand | -13.99 Thousand | 261.95 Thousand | 2.77 Million |
| Investments in PPE | - | - | - | -38.04 Thousand | -35.85 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | -13.99 Thousand | -13.99 Thousand | -38.04 Thousand | -35.85 Thousand |
| Financing Cash Flow | 684.72 Thousand | 679 Thousand | 250 Thousand | 299 Thousand | 5.4 Million |
| Debt repayment | - | -500 Thousand | -250 Thousand | -250 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 90 Thousand | - | - | - |
| Other Financing Activities | 684.72 Thousand | 679 Thousand | 250 Thousand | 299 Thousand | 5.4 Million |
| Accounts receivables | 21.31 Thousand | -220.99 Thousand | 32.41 Thousand | -21.79 Thousand | 3368.00 |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 11.53 Thousand | -2043.00 | 26.11 Thousand | -28.94 Thousand | -1.00 |
| Cash at beginning of period | 374.65 Thousand | 264.34 Thousand | 199.11 Thousand | 2.15 Million | 347.3 Thousand |
| Cash at end of period | 716.96 Thousand | 374.65 Thousand | 264.34 Thousand | 199.11 Thousand | 2.15 Million |
| Capital Expenditure | - | - | - | -38.04 Thousand | -35.85 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 342.3 Thousand | 110.31 Thousand | 65.22 Thousand | -1.95 Million | 1.8 Million |
| Free Cash Flow | -342.41 Thousand | -554.68 Thousand | -170.77 Thousand | -2.55 Million | -6.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 719.56 Thousand | -861.32 Thousand | -3.01 Million | 14.48 Million | -2.51 Million | -9.81 Million |
| Depreciation & Amortization | - | - | 2972.00 | - | - | 2543.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 471.53 Thousand | 51.53 Thousand | - | 420 Thousand |
| Change in working capital | -73.79 Thousand | -163.13 Thousand | 249.21 Thousand | 154.32 Thousand | 144.17 Thousand | -140.71 Thousand |
| Other non-cash items | -911.07 | 643.39 | 2.16 Million | -14.53 Thousand | 10.42 Thousand | 9344.33 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 684.72 Thousand | 684.72 Thousand | - | 200 Thousand |
| Debt repayment | - | - | - | - | - | -200 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 684.72 Thousand | 684.72 | - | 200.00 |
| Accounts receivables | - | - | 21.31 Thousand | 21.31 | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.96 | 6.94 | 11.53 Thousand | -83.35 | 144.17 | -140.71 |
| Cash at beginning of period | 505.97 Thousand | 716.96 Thousand | 374.65 Thousand | 93.96 Thousand | 101.45 Thousand | 90.65 Thousand |
| Cash at end of period | 321.43 Thousand | 505.97 Thousand | 716.96 Thousand | 716.96 Thousand | 93.96 Thousand | 101.45 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -184.54 Thousand | -210.98 Thousand | 342.3 Thousand | 623 Thousand | -7496.00 | 10.8 Thousand |
| Free Cash Flow | -184.54 Thousand | -210.98 Thousand | -342.41 Thousand | -61.72 Thousand | -7496.00 | -189.19 Thousand |
F-PC
FNLC
0QPU
OTCO
BGLOBAL
PTOI